Rockefeller Capital Management’s RxSight RXST Stock Holding History
Bought
Maintained
Sold
Other funds holding RXST
NSGL
Rockefeller Capital Management's RXST Position: Q2 2026 in Review
Rockefeller Capital Management reduced its RxSight (RXST) stake by 91% in Q2 2026, selling an estimated $8.11K and leaving 130 shares worth $627. The position accounts for ﹤0.01% of the portfolio, ranked #4576.
Rockefeller Capital Management first reported a position in RXST in Q3 2025 and has held it in 4 quarters since. The position peaked at $248K in Q4 2025. 152 funds tracked by Wall St. Rank hold RXST as of Q2 2026.
- Rockefeller Capital Management held 130 shares of RxSight worth $627 as of Q2 2026.
- Rockefeller Capital Management sold 1,343 RxSight shares in Q2 2026, an estimated $8.11K.
- RxSight made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #4576 holding.
- Rockefeller Capital Management first reported a position in RxSight in Q3 2025 and has held it in 4 quarters since.
- Rockefeller Capital Management's RxSight position peaked at $248K in Q4 2025.
- 152 funds tracked by Wall St. Rank held RxSight as of Q2 2026.
Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.